EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.21.46 | Lung Neoplasms |
19861453 |
- |
causal interaction ongoing research unassigned |
1 4 0 |
3.4.21.46 | Small Cell Lung Carcinoma |
19861453 |
- |
causal interaction ongoing research unassigned |
1 4 0 |
3.4.21.46 | Myocardial Infarction |
29425847 |
"All-in-one" in vitro selection of collagen-binding vascular endothelial growth factor. |
ongoing research unassigned |
4 0 |
3.4.21.46 | Neoplasms |
19470735 |
"Antimyeloangiogenic" therapy for cancer by inhibiting PlGF. |
therapeutic application unassigned |
3 0 |
3.4.21.46 | Peliosis Hepatis |
12187943 |
"Have you seen this?" peliosis hepatis. |
causal interaction unassigned |
3 0 |
3.4.21.46 | Neoplasms |
27438831 |
"On-The-Spot" Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention. |
causal interaction unassigned |
4 0 |
3.4.21.46 | Glioma |
29262608 |
"Paradoxical" findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab. |
ongoing research therapeutic application unassigned |
1 1 0 |
3.4.21.46 | Neoplasms |
29262608 |
"Paradoxical" findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab. |
ongoing research therapeutic application unassigned |
1 1 0 |
3.4.21.46 | Colorectal Neoplasms |
18095268 |
"Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy. |
ongoing research therapeutic application unassigned |
4 2 0 |
3.4.21.46 | Neoplasms |
12782586 |
"Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies. |
ongoing research unassigned |
1 0 |